Guangzhou Targene Biotech Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guangzhou Targene Biotech Co., Ltd. - overview
Established
2009
Location
Guangzhou, Guangdong, China
Primary Industry
Biotechnology
About
Based in Guangzhou, China, and established in 2009, Guangzhou Targene Biotech Co. , Ltd. is a biotechnology company that focuses on manufacturing, sales, and clinical application of in-vitro diagnostic reagents. The company has three subsidiaries, including Anhui Dajian Medical Technology Co.
, Ltd. , Wuhu Dajian Medical Testing Laboratory, and Guangzhou United Easy Inspection Medical Laboratory Co. Ltd. The Wuhu Dajian Medical Testing Laboratory provides molecular testing services, including pathogen nucleic acid testing and early tumor testing.
The Guangzhou United Easy Inspection Medical Laboratory Co. Ltd. has a pathology laboratory, gene sequencing lab, and PCR lab, and is equipped with molecular diagnostics platforms. The company provides molecular testing services, including early tumor diagnoses based on methylation testing technology.
The in-vitro diagnostic reagents can be used for diagnostic colorectal cancer, bladder cancer, liver cancer, cervical carcinoma, and thyroid cancer. The company will apply for product registration certifications, to expand its market shares, to promote the process of products under development, and to introduce talents.
Current Investors
Shandong High-tech Investment Corporation, BGI Co-WIN Investment Management, Guangzhou LBP Medicine Science & Technology Co., Ltd.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic Equipment
Website
www.gztargene.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.